Multiple sclerosis (MS) is a debilitating neurodegenerative disorder that can cause vision loss, numbness, difficulty walking, and more. This session will provide information on the latest patient management strategies and treatments that can be provided in the home setting for MS patients.
Learning Objectives:
Describe the different subtypes of multiple sclerosis (MS)
Review clinical trial and real-world efficacy and focused safety data for existing and recently approved disease modifying therapies (DMTs) for relapsing and progressive forms of MS
Discuss the evolving treatment strategies in relapsing MS
Review the risk factors of COVID-19 in MS and impact of DMTs on COVID-19 vaccine response
